Prostate cancer is one of the most common malignant tumors in men,with rapidly increasing incidence and mortality rates. Cur-rently,the advisability of performing prostate biopsy for men with PI-RADS scores of 1-3 is controversial. Aggressive biopsy may lead to over diagnosis,increasing patient suffering,whereas active surveillance may increase late diagnosis and disease progression. Accurately identify-ing cases that merit prostate biopsy is an important challenge in clinical practice. Recently,numerous studies have explored whether indi-viduals with PI-RADS scores of 1-3 should undergo prostate biopsy,but this recent research has not yet been systematically summarized and discussed. In this article,we summarize predictive factors indicating prostate biopsy in the PI-RADS 1-3 population and discuss their predict-ive value to provide new guidance for clinical practice and further research.

Prostate cancer is one of the most common malignant tumors in men,with rapidly increasing incidence and mortality rates. Cur-rently,the advisability of performing prostate biopsy for men with PI-RADS scores of 1-3 is controversial. Aggressive biopsy may lead to over diagnosis,increasing patient suffering,whereas active surveillance may increase late diagnosis and disease progression. Accurately identify-ing cases that merit prostate biopsy is an important challenge in clinical practice. Recently,numerous studies have explored whether indi-viduals with PI-RADS scores of 1-3 should undergo prostate biopsy,but this recent research has not yet been systematically summarized and discussed. In this article,we summarize predictive factors indicating prostate biopsy in the PI-RADS 1-3 population and discuss their predict-ive value to provide new guidance for clinical practice and further research.